476 related articles for article (PubMed ID: 15582691)
21. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
22. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors.
Pontarollo RA; Babiuk LA; Hecker R; van Drunen Littel-van den Hurk S
J Gen Virol; 2002 Dec; 83(Pt 12):2973-2981. PubMed ID: 12466473
[TBL] [Abstract][Full Text] [Related]
23. Induction of specific cytotoxic activity for bovine herpesvirus-1 by DNA immunization with different adjuvants.
Langellotti CA; Pappalardo JS; Quattrocchi V; Mongini C; Zamorano P
Antiviral Res; 2011 Jun; 90(3):134-42. PubMed ID: 21443903
[TBL] [Abstract][Full Text] [Related]
24. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.
Khattar SK; Collins PL; Samal SK
Vaccine; 2010 Apr; 28(18):3159-70. PubMed ID: 20189484
[TBL] [Abstract][Full Text] [Related]
25. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
26. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
27. Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine.
Loehr BI; Pontarollo R; Rankin R; Latimer L; Willson P; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2001 Dec; 82(Pt 12):3035-3043. PubMed ID: 11714981
[TBL] [Abstract][Full Text] [Related]
28. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models.
Ferrer MF; Del Médico Zajac MP; Zanetti FA; Valera AR; Zabal O; Calamante G
Viral Immunol; 2011 Aug; 24(4):331-9. PubMed ID: 21830904
[TBL] [Abstract][Full Text] [Related]
29. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
30. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.
Gogev S; de Fays K; Versali MF; Gautier S; Thiry E
Vaccine; 2004 May; 22(15-16):1946-53. PubMed ID: 15121307
[TBL] [Abstract][Full Text] [Related]
31. The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle.
Reddy PS; Idamakanti N; Pyne C; Zakhartchouk AN; Godson DL; Papp Z; Baca-Estrada ME; Babiuk LA; Mutwiri GK; Tikoo SK
Vet Immunol Immunopathol; 2000 Oct; 76(3-4):257-68. PubMed ID: 11044558
[TBL] [Abstract][Full Text] [Related]
32. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1.
Braun RP; Babiuk LA; Loehr BI; van Drunen Littel-van den Hurk
Virology; 1999 Dec; 265(1):46-56. PubMed ID: 10603316
[TBL] [Abstract][Full Text] [Related]
33. Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization.
Suradhat S; Braun RP; Lewis PJ; Babiuk LA; van Drunen Littel-van den Hurk S; Griebel PJ; Baca-Estrada ME
Vet Immunol Immunopathol; 2001 Nov; 83(1-2):79-92. PubMed ID: 11604163
[TBL] [Abstract][Full Text] [Related]
34. Bovine herpesvirus type 1 (BHV-1) is an important cofactor in the bovine respiratory disease complex.
Jones C; Chowdhury S
Vet Clin North Am Food Anim Pract; 2010 Jul; 26(2):303-21. PubMed ID: 20619186
[TBL] [Abstract][Full Text] [Related]
35. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
36. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
Chen ZH; Guo X; Ge XN; Jia H; Yang HC
Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
[TBL] [Abstract][Full Text] [Related]
37. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.
van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276
[TBL] [Abstract][Full Text] [Related]
38. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
[TBL] [Abstract][Full Text] [Related]
39. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice.
Wang KY; Guo YJ; Zhang YL; Lv K; Sun SH
Vaccine; 2007 May; 25(22):4429-36. PubMed ID: 17420075
[TBL] [Abstract][Full Text] [Related]
40. Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model.
Learmonth GS; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Arch Virol; 2003 Sep; 148(9):1805-13. PubMed ID: 14505091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
